Graphic: Vioxx Legal Resources.com
Offices

Image: Gavel & Law Books
Attorney Advertising Disclaimer

 


Vioxx News Article
Vioxx News Article
July 19, 2005
Associated Press, "Did Merck target doctors critical of Vioxx? Plaintiff's lawyer alleges company circulated list of 'physicians to neutralize'"
          Merck & Co.'s marketing team targeted doctors viewed as unfriendly toward Vioxx to bring them into the fold, neutralize or discredit them, the plaintiff's lawyer in the nation's first Vioxx-related lawsuit to go to trial alleged Tuesday.
          Nancy Santanello, head of Merck's epidemiology department, was questioned about an internal list of 36 doctors identified as "physicians to neutralize" in an e-mail circulated two months after the popular painkiller went on the market in 1999.
          "Attached is the complete list of 36 physicians to neutralize with background information and recommended tactics. You will notice that some have already been 'neutralized,'" the e-mail said. It also said a previous e-mail had a subset of the 36 physicians "we would like to get involved in Merck clinical research" and that the e-mail's recipient should "be aware of our most challenging (and also most vocal) national and regional physicians."
          Santanello said the term, "neutralize" was a marketing strategy to educate doctors about Vioxx.
          "I'm not a marketing person. What the marketing people do is ask the scientists to meet with the physician and explain the data to them," she told jurors.
          Santanello is Merck's corporate face among the company's team of lawyers and continued absorbing verbal punches from Lanier regarding the ethics of Merck's marketing and commitment to safe drugs.
          The prosecuting attorney pressed her about written recommendations to gain each doctor's support for Vioxx. In one case, the document said, "Show me the money" and then noted Merck had provided him with $25,000 to support a program to examine treatment of arthritis. In another case, the document said "discredit" next to the name of a doctor allegedly deemed unwilling to be swayed.

Lieff Cabraser: Experienced Vioxx Injury Lawyers
Founded in 1972, Lieff Cabraser Heimann & Bernstein, LLP is an over-fifty attorney law firm with offices in San Francisco, New York and Nashville. In each of the last five years, the National Law Journal has recognized Lieff Cabraser as one of the top plaintiffs’ law firms in America.
For our personal injury Vioxx cases, we bring a team of experienced lawyers. In addition, we have on staff multiple nurses, legal assistants, scientific analysts and case clerks to assist our Vioxx attorneys. Learn more about advantages we offer patients with Vioxx problems and injuries.
OUR PROMISE TO YOU
We have a nationwide team of experienced injury Vioxx lawyers assigned to Vioxx trials.
We provide individual attentive service. Learn more about our firm.
We have retained the leading national medical experts on Vioxx and have a staff of nurses to assist the prosecution of the claims of our clients.
We have been contacted by thousands of Vioxx drug patients nationwide as part of the Vioxx litigation. We have represented patients who ingested prescription drugs with dangerous, undisclosed side effects in personal injury lawsuits across America, including residents of Alaska, Alabama, Arkansas, Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Washington, Wisconsin, West Virginia and Wyoming.
Persons living outside the United States who have been injured by an American product manufactured may also in certain cases file Vioxx lawsuits for compensation for heart attacks and strokes in United States courts.

Photo: Supreme Court, Gavel & Law Books, Scales, various pill images
Lieff Cabraser Heimann & Bernstein, LLP

Trademark Notice
"Vioxx" is a registered trademark of Merck. Lieff Cabraser Heimann & Bernstein, LLP is in no way affiliated with Merck, and the Vioxx trademark is used solely for informational purposes.

Copyright © 2008 Lieff Cabraser Heimann & Bernstein, LLP

Vioxx Recall: The international prescription drug company Merck announced in September 2004 the worldwide withdrawal of the arthritis medication Rofecoxib, sold in most countries under the brand name Vioxx, because a study showed an increased risk of heart attack and stroke.

Vioxx Trial: Patients who have suffered injuries due to Vioxx have filed litigation against Merck for selling Vioxx even though Merck allegedly was aware of Vioxx's dangerous side effects.